Manjakkollai Veerabagu, MD
Gastroenterology · Anderson, SCNPI 1952309049
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $20,375 of the $24,354 with a category attached, or 83.7%. It is spread thinly across 50 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $6,216, 2.6 times the $2,397 reported in 2019. Among gastroenterology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,072 payments — averaging $22.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Boston Scientific$2K
- Johnson & Johnson$2K
- Olympus Corporation Of The Americas$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- plus $11K from 44 others
What the payments were for
- Grants$290%
- Travel & lodging$3,56515%
- Food & beverage$20,37584%
- Education$3862%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DISPOSABLE DISTAL ATTACHMENT$1,723
- Single Use Electrosurgical Knife KD-655$1,157
- Apollo ESG NXT System$850
- Olympus$566
- ORISE$440
- GENERAL - THERAPIES$409
- SPEEDBOAT$375
- OverStitch Endoscopic Suturing System$350
- STELARA$246
- REZDIFFRA$134
- ZYMFENTRA$125
- Tremfya$123
- Reltone 200 Mg$122
- Reltone 400 Mg$122
- Creon$121
- Single Use Electrosurgical Hemostatic Forceps$120
- Single Use Repositionable Clip$120
- Rinvoq$120
- VOQUEZNA$108
- BOTOX$108
How this compares
$24,354 in reported general payments places this provider in the 90th percentile of 259 gastroenterology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 14 | $333,007 |
| SucraidSacrosidase | 13 | $183,418 |
| XifaxanRifaximin | 34 | $114,024 |
| RinvoqUpadacitinib | 13 | $82,927 |
| LinzessLinaclotide | 77 | $57,847 |
| ZenpepLipase/Protease/Amylase | 21 | $45,195 |
| CreonLipase/Protease/Amylase | 18 | $26,782 |
| VemlidyTenofovir Alafenamide | 12 | $16,953 |
| PentasaMesalamine | 13 | $8,056 |
| TrulancePlecanatide | 13 | $7,680 |
| Dexlansoprazole DrDexlansoprazole | 17 | $5,370 |
| Ursodiol | 25 | $3,697 |
| Pantoprazole Sodium | 360 | $3,557 |
| Colesevelam Hcl | 29 | $3,316 |
| Famotidine | 139 | $3,310 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $2,140 | $333,00714 claims |
| QOL Medical, LLCSucraid | $252 | $183,41813 claims |
| AbbVieRinvoq, Linzess, Creon | $4,761 | $167,556108 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $1,410 | $121,70447 claims |
| Aimmune Therapeutics, Inc.Zenpep | $273 | $45,19521 claims |
| GileadVemlidy | $883 | $16,95312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 259 gastroenterology providers in South Carolina.
Other gastroenterology in Anderson
- David WorthamAnderson$10K
- Erin ForsterCharleston$788K
- Mark DeleggeCharleston$568K
- Nathan ShoresCharleston$217K
- Andre EaddyGreenville$212K
- Alejandro SuarezCharleston$210K
- Veeral OzaGreenville$199K
- Peter CottonCharleston$193K
- Christina BauerGreenville$179K
- Andrew PearsonMyrtle Beach$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.